Fumaric Acid

Fumaric Acid

SCHEMBL5865119

CCc1cc(N)cc(C2=Cc3cc(Cl)ccc3CC2)n1.O=C(O)C=CC(=O)O

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 1/20 0.32
ADRA1D known ✓ P25100 1/20 0.31
ADRA1A known ✓ P35348 1/20 0.31
ADRA1B known ✓ P35368 1/20 0.31
ALOX15 P16050 1/20 0.32
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
CHRM1 P11229 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
MCHR1 Q99705 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL27608452 1.00 HRH1 (0.32) HRH1ALOX15GRIN2DGRIN3BCHRM1
Fumaric Acid SCHEMBL5865108 1.00 HRH1 (0.32) HRH1ALOX15GRIN2DGRIN3BCHRM1
SCHEMBL5865363 0.91 GRIN2D (0.36) GRIN2DGRIN3BCHRM1ADRA1DADRA1A
Fumaric Acid SCHEMBL5865369 0.87 GRIN2D (0.39) GRIN2DGRIN3BCHRM1ADRA1DADRA1A
Fumaric Acid SCHEMBL5865379 0.87 GRIN2D (0.39) GRIN2DGRIN3BCHRM1ADRA1DADRA1A
Fumaric Acid SCHEMBL27608454 0.87 GRIN2D (0.39) GRIN2DGRIN3BCHRM1ADRA1DADRA1A
Fumaric Acid SCHEMBL5865003 0.87 HRH1 (0.33) HRH1ALOX15
Fumaric Acid SCHEMBL5865013 0.87 HRH1 (0.33) HRH1ALOX15
Fumaric Acid SCHEMBL27608455 0.87 HRH1 (0.33) HRH1ALOX15
Fumaric Acid SCHEMBL5865311 0.80 HRH1 (0.36) HRH1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034044-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2006-04-25 US disclosed
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER 2006-03-16 US disclosed
EP-1443926-A1 PYRIDINE DERIVATIVES AS NMDA-RECEPTOR SUBTYPE BLOCKERS F. HOFFMANN-LA ROCHE AG (CH) 2004-08-11 EP disclosed
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER (FR) 2004-04-08 US disclosed
WO-2003037333-A1 PYRIDINE DERIVATIVES AS NMDA-RECEPTOR SUBTYPE BLOCKERS F. HOFFMANN-LA ROCHE AG (CH) 2003-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C HRH1 402/4885ADRA1D 117/4885ADRA1A 123/4885
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN3A, GRIN2C HRH1 376/4885ADRA1D 172/4885ADRA1A 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.